Vident Advisory’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.51M | Sell |
50,198
-46,982
| -48% | -$3.28M | 0.04% | 356 |
|
|
2025
Q1 | $7.14M | Buy |
97,180
+63,601
| +189% | +$4.68M | 0.1% | 181 |
|
|
2024
Q4 | $2.2M | Sell |
33,579
-1,521
| -4% | -$99.7K | 0.04% | 390 |
|
|
2024
Q3 | $2.73M | Buy |
35,100
+5,165
| +17% | +$402K | 0.07% | 311 |
|
|
2024
Q2 | $2.33M | Buy |
29,935
+8,411
| +39% | +$656K | 0.06% | 316 |
|
|
2024
Q1 | $1.46M | Sell |
21,524
-629
| -3% | -$42.6K | 0.03% | 468 |
|
|
2023
Q4 | $1.49M | Buy |
22,153
+447
| +2% | +$30.1K | 0.04% | 454 |
|
|
2023
Q3 | $1.47M | Buy |
+21,706
| New | +$1.47M | 0.05% | 401 |
|